BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18199920)

  • 1. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
    White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
    Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
    Segura J; Ruilope LM
    Vasc Health Risk Manag; 2013; 9():521-8. PubMed ID: 24082785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
    Higaki J; Komuro I; Shiki K; Ugai H; Taniguchi A; Ikeda H; Kuroki D; Nishimura S; Ogihara T
    Hypertens Res; 2017 Jan; 40(1):51-60. PubMed ID: 27581533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertension.
    Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S
    Oxid Med Cell Longev; 2010; 3(5):342-6. PubMed ID: 21150340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
    Sowers JR; Raij L; Jialal I; Egan BM; Ofili EO; Samuel R; Zappe DH; Purkayastha D; Deedwania PC
    J Hypertens; 2010 Aug; 28(8):1761-9. PubMed ID: 20498618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
    Oparil S; Giles T; Ofili EO; Pitt B; Seifu Y; Hilkert R; Samuel R; Sowers JR
    J Hypertens; 2011 Jan; 29(1):161-70. PubMed ID: 21045734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trial.
    Huber M; Treutler T; Martus P; Kurzidim A; Kreutz R; Beige J
    PLoS One; 2013; 8(11):e79322. PubMed ID: 24260194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
    Maillard MP; Burnier M
    Vasc Health Risk Manag; 2007; 3(3):265-78. PubMed ID: 17703634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANAGEMENT OF RISKS OF ADVERSE DRUG REACTIONS ACCORDING TO ADR REPORT FORM DATA FROM LVIV REGION HEALTHCARE FACILITIES IN 2022.
    Stepaniuk N; Piniazhko O; Poshyvak O; Bessarab T; Hudz N; Gavriluk I
    Georgian Med News; 2023; (340-341):76-80. PubMed ID: 37805878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of telmisartan versus valsartan on post-induction hypotension during noncardiac surgery: a prospective observational study.
    Oh CS; Park JY; Kim SH
    Korean J Anesthesiol; 2024 Jun; 77(3):335-344. PubMed ID: 38311886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk.
    Li Y; Li XH; Huang ZJ; Yang GP; Zhang GG; Zhao SP; Guo Y; Lu SJ; Ma JL; Meng FB; Chen P; Yuan H
    PLoS One; 2015; 10(2):e0117560. PubMed ID: 25693004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical advantage of valsartan.
    McInnes GT
    Cardiology; 1999; 91 Suppl 1():14-8. PubMed ID: 10449890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Year Cardiovascular Outcomes of Telmisartan in Patients With Hypertension: An Electronic Health Record-Based Cohort Study.
    Yum Y; Kim JH; Joo HJ; Kim YH; Kim EJ
    Am J Hypertens; 2024 May; 37(6):429-437. PubMed ID: 38285627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern.
    Wang C; Zhang J; Liu X; Li CC; Ye ZC; Peng H; Chen Z; Lou T
    J Clin Hypertens (Greenwich); 2013 Jan; 15(1):48-54. PubMed ID: 23282124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review].
    Zakiev VD; Kotovskaya YV; Tkacheva ON
    Ter Arkh; 2023 Nov; 95(9):810-817. PubMed ID: 38158926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial.
    Morris DR; Cunningham MA; Ahimastos AA; Kingwell BA; Pappas E; Bourke M; Reid CM; Stijnen T; Dalman RL; Aalami OO; Lindeman JH; Norman PE; Walker PJ; Fitridge R; Bourke B; Dear AE; Pinchbeck J; Jaeggi R; Golledge J
    Trials; 2015 Jun; 16():274. PubMed ID: 26081587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of six angiotensin II receptor blockers in hypertensive patients: a network meta-analysis.
    Zhang Z; Yang H; Guo H
    Int J Clin Pharm; 2024 Jun; ():. PubMed ID: 38861046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide.
    Soria-Chacartegui P; Zubiaur P; Ochoa D; Navares-Gómez M; Abbes H; Villapalos-García G; de Miguel A; González-Iglesias E; Rodríguez-Lopez A; Mejía-Abril G; Martín-Vilchez S; Luquero-Bueno S; Román M; Abad-Santos F
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of telmisartan on endothelial function and arterial stiffness in patients with essential hypertension.
    Jung AD; Kim W; Park SH; Park JS; Cho SC; Hong SB; Hwang SH; Kim W
    Korean Circ J; 2009 May; 39(5):180-4. PubMed ID: 19949576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of triple therapy (ramipril, telmisartan, hydrochlorothiazide) vs dual anti hypertensive therapy (ramipril or telmisartan, hydrochlorothiazide) in stage 2 hypertensive patients.
    Bhushan B; Gupta S; Khajuria V; Kumar D; Lal M; Kumar D; Bhat S; Sharma A
    J Clin Diagn Res; 2014 Aug; 8(8):HC25-8. PubMed ID: 25302216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.